107 related articles for article (PubMed ID: 21803112)
1. Divergent effects of lithium and sodium valproate on brain-derived neurotrophic factor (BDNF) production in human astrocytoma cells at therapeutic concentrations.
Nishino S; Ohtomo K; Numata Y; Sato T; Nakahata N; Kurita M
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):17-22. PubMed ID: 21803112
[TBL] [Abstract][Full Text] [Related]
2. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.
Yasuda S; Liang MH; Marinova Z; Yahyavi A; Chuang DM
Mol Psychiatry; 2009 Jan; 14(1):51-9. PubMed ID: 17925795
[TBL] [Abstract][Full Text] [Related]
3. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes.
Chen PS; Peng GS; Li G; Yang S; Wu X; Wang CC; Wilson B; Lu RB; Gean PW; Chuang DM; Hong JS
Mol Psychiatry; 2006 Dec; 11(12):1116-25. PubMed ID: 16969367
[TBL] [Abstract][Full Text] [Related]
4. Sodium butyrate and mood stabilizers block ouabain-induced hyperlocomotion and increase BDNF, NGF and GDNF levels in brain of Wistar rats.
Varela RB; Valvassori SS; Lopes-Borges J; Mariot E; Dal-Pont GC; Amboni RT; Bianchini G; Quevedo J
J Psychiatr Res; 2015 Feb; 61():114-21. PubMed ID: 25467060
[TBL] [Abstract][Full Text] [Related]
5. Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells.
Castro LM; Gallant M; Niles LP
J Neurochem; 2005 Dec; 95(5):1227-36. PubMed ID: 16313512
[TBL] [Abstract][Full Text] [Related]
6. Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain.
Jornada LK; Moretti M; Valvassori SS; Ferreira CL; Padilha PT; Arent CO; Fries GR; Kapczinski F; Quevedo J
J Psychiatr Res; 2010 Jun; 44(8):506-10. PubMed ID: 19954800
[TBL] [Abstract][Full Text] [Related]
7. Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain.
Fukumoto T; Morinobu S; Okamoto Y; Kagaya A; Yamawaki S
Psychopharmacology (Berl); 2001 Oct; 158(1):100-6. PubMed ID: 11685390
[TBL] [Abstract][Full Text] [Related]
8. Effects of lithium and valproic acid on BDNF protein and gene expression in an in vitro human neuron-like model of degeneration.
Croce N; Mathé AA; Gelfo F; Caltagirone C; Bernardini S; Angelucci F
J Psychopharmacol; 2014 Oct; 28(10):964-72. PubMed ID: 24699060
[TBL] [Abstract][Full Text] [Related]
9. Sodium valproate at therapeutic concentrations changes Ca2+ response accompanied with its weak inhibition of protein kinase C in human astrocytoma cells.
Kurita M; Nishino S; Ohtomo K; Rai M; Shirakawa H; Mashiko H; Niwa S; Nakahata N
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):600-4. PubMed ID: 17258372
[TBL] [Abstract][Full Text] [Related]
10. The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells.
Laeng P; Pitts RL; Lemire AL; Drabik CE; Weiner A; Tang H; Thyagarajan R; Mallon BS; Altar CA
J Neurochem; 2004 Oct; 91(1):238-51. PubMed ID: 15379904
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid mediates the synaptic excitatory/inhibitory balance through astrocytes--a preliminary study.
Wang CC; Chen PS; Hsu CW; Wu SJ; Lin CT; Gean PW
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):111-20. PubMed ID: 22343008
[TBL] [Abstract][Full Text] [Related]
12. Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers.
Watson DG; Watterson JM; Lenox RH
J Pharmacol Exp Ther; 1998 Apr; 285(1):307-16. PubMed ID: 9536026
[TBL] [Abstract][Full Text] [Related]
13. Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania.
Frey BN; Andreazza AC; Ceresér KM; Martins MR; Valvassori SS; Réus GZ; Quevedo J; Kapczinski F
Life Sci; 2006 Jun; 79(3):281-6. PubMed ID: 16460767
[TBL] [Abstract][Full Text] [Related]
14. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
Lenox RH; McNamara RK; Watterson JM; Watson DG
J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
[TBL] [Abstract][Full Text] [Related]
15. Antidepressive effect of sodium valproate involving suppression of corticotropin-releasing factor expression and elevation of BDNF expression in rats exposed to chronic unpredicted stress.
Qiu HM; Yang JX; Liu D; Fei HZ; Hu XY; Zhou QX
Neuroreport; 2014 Mar; 25(4):205-10. PubMed ID: 24128869
[TBL] [Abstract][Full Text] [Related]
16. Effects of mood-stabilizing drugs on dendritic outgrowth and synaptic protein levels in primary hippocampal neurons.
Park SW; Lee JG; Seo MK; Cho HY; Lee CH; Lee JH; Lee BJ; Baek JH; Seol W; Kim YH
Bipolar Disord; 2015 May; 17(3):278-90. PubMed ID: 25307211
[TBL] [Abstract][Full Text] [Related]
17. Strain-specific BDNF expression of rat primary astrocytes.
Wei R; Lin CM; Tu YY
J Neuroimmunol; 2010 Mar; 220(1-2):90-8. PubMed ID: 20176405
[TBL] [Abstract][Full Text] [Related]
18. [Neuroprotective actions of lithium].
Hashimoto R; Fujimaki K; Jeong MR; Senatorov VV; Christ L; Leeds P; Chuang DM; Takeda M
Seishin Shinkeigaku Zasshi; 2003; 105(1):81-6. PubMed ID: 12701214
[TBL] [Abstract][Full Text] [Related]
19. The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1.
Plant KE; Anderson E; Simecek N; Brown R; Forster S; Spinks J; Toms N; Gibson GG; Lyon J; Plant N
Toxicol Appl Pharmacol; 2009 Feb; 235(1):124-34. PubMed ID: 19101580
[TBL] [Abstract][Full Text] [Related]
20. Serum protein levels of brain-derived neurotrophic factor and tropomyosin-related kinase B in bipolar disorder: effects of mood stabilizers.
Huang TL; Hung YY; Lee CT; Chen RF
Neuropsychobiology; 2012; 65(2):65-9. PubMed ID: 22222435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
